Brendan Hannah
Director of Finance/CFO at QUINCE THERAPEUTICS, INC.
Net worth: 207 602 $ as of 30/04/2024
Brendan Hannah active positions
Companies | Position | Start | End |
---|---|---|---|
QUINCE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 16/03/2023 | - |
Chief Operating Officer | 24/10/2023 | - | |
Director of Finance/CFO | 16/03/2023 | - | |
Corporate Officer/Principal | 01/05/2022 | 16/03/2023 | |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Chief Operating Officer | - | - |
Career history of Brendan Hannah
Former positions of Brendan Hannah
Companies | Position | Start | End |
---|---|---|---|
CIDARA THERAPEUTICS, INC. | Corporate Officer/Principal | - | 01/12/2016 |
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Training of Brendan Hannah
University of California | Masters Business Admin |
Statistics
International
United States | 6 |
Operational
Corporate Officer/Principal | 3 |
Chief Operating Officer | 2 |
Comptroller/Controller/Auditor | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
QUINCE THERAPEUTICS, INC. | Health Technology |
CIDARA THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Brendan Hannah
- Experience